Supreme Court Hears Patent Case Challenged by Drugmakers

摘要

High-tech drugmakers are hoping that oral arguments heard by the U.S. Supreme Court last week in a patent case will encourage the court to overturn an appeals court decision that could make patents for certain products difficult or impossible to obtain.rnThe case would have an extreme adverse impact on the kinds of patents for which the pharmaceutical industry could file, the Biotechnology Industry Organization (BIO) says earlier this year in an amicus brief it filed with other parties in the case (WDL, Aug. 24).